Drug development, whether in biotech, or pharma, is extremely challenging. With only 1 in 8 Phase 2 drugs getting to launch, increasing development predictability and de-risking the process is essential. Development teams face challenges in decision-making and in communicating the potential benefits of their products. Teams can quickly become overloaded with data, yet be information-poor – leading to delays and cost overruns. We're called Decision Point 1 because that's when we work. At the time when far-reaching investment decisions must be made. With over 30 years’ drug development experience, we’re the premier technology transfer/knowledge management company serving biotech and pharmaceutical companies: • Biotech: we help ensure maximum stakeholder value, by enhancing the perceived value of the development product. This helps achieve the most favourable terms with potential development partners • Pharma: we manage technology transfers for in-licensed products and help development teams improve, and speed up, decision making and communication We focus on the early-phase drug development stage and have four main service areas: • Biotech: preparing proprietary information platforms supporting out-licensing and recruitment of development partners • Biotech: facilitating and moderating Scientific Advisory Boards, to ensure the highest quality external input to the development process • Pharma (in-house products): internal information audit (Discovery to Phase 2) and information needs assessment • Pharma (in-licensed products): management of technology transfer process from originator to development partner; including comprehensive information platforms and product training Our extensive international experience with both biotech and pharma companies can help improve your drug development process. Contact: info@decisionpoint1.com.